Delivery Order SPE2DB24D9245-SPE2DB24FHMHS

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $1,413.24 for the supply of pharmaceutical products, including medications such as fluticasone propionate. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which supports the recurring medical supply needs of military health facilities and VA medical centers nationwide. The contract is a firm...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) to provide a range of pharmaceutical products. The contract, valued up to $2,284.16, is a delivery order under the DLA's SPE2DB program, which is an indefinite delivery vehicle (IDV) with a ceiling of up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical Group will fulfill recurring medical supply needs of military health facilities, including...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under the SPE2DB program. The $4,716.94 contract covers the delivery of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price Delivery Order valued at $2,798.95 with a period of performance through February 28, 2024. The award was made by the Defense Logistics Agency (DLA) and encompasses the supply of various pharmaceutical products, including medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This Delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract. The IDC, valued at up to $499,999,999, covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. The specific delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $1,187.55 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) for the SPE2DB program. The IDC, valued at $499,999,999, provides the DLA with firm fixed-price delivery orders for a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to...
This federal contract award is for a delivery order with a firm fixed price of $4,311.35 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the provision of a range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military healthcare...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order from the Defense Logistics Agency (DLA) valued at $4,928.68. The contract is for the delivery of a variety of pharmaceutical products, including medications and medical supplies, to support the medical needs of military health facilities globally. This order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA, contract SPE2DB-13-D-4600, which has a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $12,934.05. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). DMS Pharmaceutical Group specializes in supplying a wide range of branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $2,873.20 for the supply of HADLIMA PUSHTOUCH 40 MG/0.8 ML 0.8ML to the Defense Logistics Agency (DLA). The contract is a firm fixed-price award and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to provide a...
  • SPE2DB24D9245
    Indefinite Delivery Contract
  • SPE2DB24D9245-SPE2DB24FHMHS
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $3,848.60 issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract provides for the delivery of 4,565,252,933 tablets of the generic drug Tamsulosin Hydrochloride 0.4 mg to the DLA by July 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. As a woman-owned small business, DMS Pharmaceutical Group has secured this direct award without any set-aside designation, leveraging its status to become a crucial supplier in the federal pharmaceutical supply chain.

Generated 10/23/24, 9:37 AM